Generics

FDA gives tentative nod to Zydus Cadila for generic Tradjenta
Zydus Cadila’s linagliptin tablets will be available in a dosage strength of 5 mg, pending the Food and Drug Administration's final approval.
Aurobindo sells Natrol to New Mountain Capital
Proceeds from Aurobindo's divestiture of Natrol will be used to reduce debt and develop other new strategic initiatives, according to the company.

Alembic obtains FDA nod for 2 generics

Tavaborole topical solution had a market value of roughly $82 million and fenofibrate capsules had a market value of $17 million, for the 12 months ended June 2020.
FDA gives Zydus Cadila tentative OK for generic Xeljanz

Zydus Cadila's generic Xeljanz XR tablets provide a once-daily treatment for adult patients with moderately to severely active ulcerative colitis.
Ascend Labs’ VanWinkle named Cardinal Health’s generic trade rep of the year

Schuyler VanWinkle has been recognized by Cardinal Health as Generic Trade Representative of the Year for the second time in three years.
Zydus Cadila receives FDA blessing for 2 generics

The FDA has granted approval for Zydus Cadila's generic Proventil, and generic Vesicare.
Dr. Reddy’s relaunches OTC generic famotidine tablets

The company is re-launching its famotidine tablets in 10- and 20-mg tablets, store-brand equivalents of original strength and maximum strength Pepcid AC.
FDA clears Glenmark’s generic Rapamune tablets

Rapamune and its generics had annual sales of $119.7 million for the year ended August 2020, according to IQVIA data.
Cardinal Health honors Upsher-Smith's Leonard, Dearborn

Upsher Smith's Brad Leonard, associate vice president of national accounts, and Amy Dearborn, senior manager of customer relations & order management, received top honors from Cardinal Health.
Alembic receives FDA nod for generic Symmetrel

Amantadine hydrochloride tablets have a market value of roughly $13 million for the 12 months ended June 2020, according to IQVIA.

FDA gives tentative nod to Zydus Cadila for generic Tradjenta

Aurobindo sells Natrol to New Mountain Capital

Alembic obtains FDA nod for 2 generics

FDA gives Zydus Cadila tentative OK for generic Xeljanz

Ascend Labs’ VanWinkle named Cardinal Health’s generic trade rep of the year

Zydus Cadila receives FDA blessing for 2 generics

Dr. Reddy’s relaunches OTC generic famotidine tablets

FDA clears Glenmark’s generic Rapamune tablets

Cardinal Health honors Upsher-Smith's Leonard, Dearborn

Alembic receives FDA nod for generic Symmetrel